Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Acorda, Actinium, Astellas, Auravax, Biodesix, Cytokinetics, Cytovia, Diurnal, Eloxx, Esperion, Essa, Genevant, Genmab, Genprex, Graphite, Hemogenyx, Hibercell, J&J, Jaguar, Jasper, Ji Xing, Kaken, Kamada, Khondrion, Ligand, Marker, Merck, Napo, Numab, Omega RDIF, Regeneron, Roche, Salarius, Sarepta, Serometrix, Taysha, União Química, Urogen .